Last reviewed · How we verify

NCT03896698: TUS

Feasibility Study of Transcranial Ultrasound Stimulation on Alzheimer's Disease Patients

Status unknown NA Last updated 28 April 2020
What this trial tests

NA trial testing Transcranial Ultrasound Stimulation in Alzheimer Disease in 10 participants. Status unknown.

Timeline
23 August 2019
Primary endpoint
31 May 2021
30 June 2021

Quick facts

Lead sponsorNational Yang Ming Chiao Tung University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposedevice feasibility
Enrollment10
Start date23 August 2019
Primary completion31 May 2021
Estimated completion30 June 2021
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Yang Ming Chiao Tung University

Who can join

Adults 55 to 90, any sex, with Alzheimer Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Currently, the main treatment method for Alzheimer's disease (AD) is chemotherapy. However, the effectiveness of drugs is moderate and there are several side effects. In this clinical trial, the investigators would like to activate the brain by the transcranial ultrasound stimulation (TUS). This is a feasibility study to evaluate the safety and initial effectiveness of TUS for the treatment of patients with mild AD.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Current state of clinical ultrasound neuromodulation.
    Matt E, Radjenovic S, Mitterwallner M, Beisteiner R. · · 2024 · cited 27× · PMID 38962179 · DOI 10.3389/fnins.2024.1420255
  2. Volume Changes in Brain Subfields of Patients with Alzheimer's Disease After Transcranial Ultrasound Stimulation.
    Huang SY, Wu MT, Sun CF, Yang FY. · · 2025 · cited 1× · PMID 39941289 · DOI 10.3390/diagnostics15030359

Verify or expand the search:

Other recruiting trials for Alzheimer Disease

Currently open trials in the same condition.

Other National Yang Ming Chiao Tung University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03896698.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing